Cytokeratin 5/14-positive breast cancer: true basal phenotype confined to BRCA1 tumors (Q42480689)

1 November 2017

Cytokeratin 5/14-positive breast cancer: true basal phenotype confined to BRCA1 tumors (English)

1 reference

1 November 2017

1 reference

1 reference

Mervi Laakso

1

1 reference

1 November 2017

Niklas Loman

series ordinal

2

1 reference

1 November 2017

Ake Borg

series ordinal

3

1 reference

1 November 2017

Jorma Isola

series ordinal

4

1 reference

1 November 2017

1 October 2005

1 reference

1 November 2017

1 reference

1 November 2017

18

1 reference

1 November 2017

1321-1328

1 reference

1 November 2017

10

1 reference

https://scigraph.springernature.com/pub.10.1038/modpathol.3800456

1 November 2017

0 references

cites work

The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800456

Keratin expression in human tissues and neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800456

Expression of luminal and basal cytokeratins in human breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800456

Evidence of progenitor cells of glandular and myoepithelial cell lineages in the human adult female breast epithelium: a new progenitor (adult stem) cell concept

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800456

Molecular portraits of human breast tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800456

Different proliferative activity of the glandular and myoepithelial lineages in benign proliferative and early malignant breast diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800456

Expression of cytokeratins 17 and 5 identifies a group of breast carcinomas with poor clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800456

Breast cell invasive potential relates to the myoepithelial phenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800456

Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800456

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800456

Repeated observation of breast tumor subtypes in independent gene expression data sets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800456

The prognostic implication of the basal-like (cyclin E high/p27 low/p53+/glomeruloid-microvascular-proliferation+) phenotype of BRCA1-related breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800456

Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800456

p63, a p53 homologue, is a selective nuclear marker of myoepithelial cells of the human breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800456

Differential expression of p63 isoforms in normal tissues and neoplastic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800456

p63 expression in normal, hyperplastic and malignant breast tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800456

Distribution of p63, cytokeratins 5/6 and cytokeratin 14 in 51 normal and 400 neoplastic human tissue samples using TARP-4 multi-tumor tissue microarray

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800456

Hierarchical clustering analysis of tissue microarray immunostaining data identifies prognostically significant groups of breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800456

Interlaboratory comparison of HER-2 oncogene amplification as detected by chromogenic and fluorescence in situ hybridization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800456

Use of p63/P504S monoclonal antibody cocktail in immunohistochemical staining of prostate tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800456

Cytokeratin 5/6 in normal human breast: lack of evidence for a stem cell phenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800456

NCL-5D3: a new monoclonal antibody recognizing low molecular weight cytokeratins effective for immunohistochemistry using fixed paraffin-embedded tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800456

BRCA1 functions as a breast stem cell regulator

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800456

Quantitative association between HER-2/neu and steroid hormone receptors in hormone receptor-positive primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800456

Biological and prognostic significance of stratified epithelial cytokeratins in infiltrating ductal breast carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800456

7 January 2021

Cytogenetic alterations and cytokeratin expression patterns in breast cancer: integrating a new model of breast differentiation into cytogenetic pathways of breast carcinogenesis.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800456

7 January 2021

Usual ductal hyperplasia of the breast is a committed stem (progenitor) cell lesion distinct from atypical ductal hyperplasia and ductal carcinoma in situ

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800456

7 January 2021

Cytokeratin 5/6 immunohistochemistry assists the differential diagnosis of atypical proliferations of the breast

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800456

7 January 2021

Family history of breast and ovarian cancers and BRCA1 and BRCA2 mutations in a population-based series of early-onset breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800456

7 January 2021

10.1038/MODPATHOL.3800456

Identifiers

DOI

1 reference

Dimensions Publication ID

1 November 2017

0 references

1 reference